Clinical Trial Update: Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia [NA]

View source ↗

Summary

This clinical trial update reports the metabolic effects of an 8-week Niaspan (extended-release niacin) treatment in adults with abdominal obesity and mixed dys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Obesity

Drugs mentioned

• Niaspan (niacin (nicotinic acid))

Snippet

Sponsor: Centre de Recherche en Nutrition Humaine Rhone-Alpe | Conditions: Insulin Sensitivity, Lipoproteins Metabolism | NA | Status: COMPLETED